Mr. G V Prasad leads the core team that is driving the company's growth and transformation from a company predominantly selling API, Branded Formulations & Generics to achieving its vision of becoming a discovery-led global pharmaceutical company.

As CEO, Mr. Prasad has championed the globalization of the company and has played a vital role in the company's evolution. He has been the architect of the company's global generics strategy. He has helped create new platforms of growth for Dr. Reddy's, in the Custom Pharmaceutical Services, Discovery Services and Specialty Pharmaceutical segments. He has built a diverse, talented and experienced senior management team in India, Europe and the US. Currently he is focused on driving Dr. Reddy's growth in the two largest geographies - US and Europe.

Mr. Prasad has a Bachelors degree in Chemical Engineering from Illinois Institute of Technology, Chicago (1982), and a Masters in Industrial Administration from Purdue University (1983).

Joe leads a section of GE's Diagnostic Imaging business focused on value products and solutions for customers around the world.

Performance Technologies includes the GoldSeal refurbished and remanufactured products business and the Primary Care emerging markets business. The mission of these businesses is to provide high-quality, affordable Diagnostic Imaging systems to customers whose needs are great but whose budgets are not.

Joe has been in GE Healthcare since 2001. Following an assignment as Six Sigma Quality Leader for the Americas Diagnostic Imaging business, he was appointed as General Manager of GoldSeal in 2003. In 2005 his role was expanded to include Primary Care for emerging markets as Performance Technologies GM.

Before coming to Healthcare, Joe spent 15 years in a variety of other GE businesses and positions, most recently as Managing Director of GE Quartz Europe from 1999 to 2001 and GE Quartz Asia Pacific Operations GM from 1995 to 1998.

Joe earned a Bachelor of Science in Economics degree from the Wharton School and a Bachelor of Science in Electrical Engineering from the Moore School, both at the University of Pennsylvania, in 1986.

Hooman has a strong background in strategic planning, marketing, working with KOL's and medical societies, and e-business in both clinical and commercial healthcare environments. He has an MBA from the Kellogg School of Northwestern University and currently holds a faculty appointment at a major university medical center.

In addition to founding MedSphere, Hooman has more than 10 years of experience with international pharmaceutical companies and 10 years in multiple responsible positions in a leading university medical center. He is a regular invited speaker at university and pharmaceutical conferences on strategy, marketing, technology, and negotiations.

Dr.Anil Khurana is a director in the Operational Strategy and Private Equity practice at PRTM, where he leads client engagements focused on driving breakout business performance based on operational innovation. He has more than 20 years experience in operations, consulting, government, private equity, and academia.

Dr. Khurana's main areas of expertise are operational strategy, mergers and acquisitions, global strategy and globalization, and innovation. He works across industries, having worked with clients in private equity, industrial, durable goods, IT/ business services, devices, and biotech/ pharmaceuticals. In addition, Anil has worked on several government and energy (oil and gas) projects.

Dr. Khurana has been featured by CNBC, The Boston Globe, Mass High Tech, and others. He has been a National Science Foundation award winner, a Ford scholar, and a winner of several Best Dissertation and Best Article awards. He has published in the Sloan Management Review and other journals and conferences, on themes such as innovation, global operations, global innovation networks, operational strategy, M&A, knowledge-based economies, and privatization.

Dr. Khurana obtained his undergraduate degrees in India in engineering and economics, and his Masters of Science, Masters of Business Administration, and PhD degrees in engineering and management from University of Michigan.

Sanuj K. Ravindran, M.D. is a Principal of Radius Ventures, LLC. Prior to joining Radius in February 2007, Sanuj was a Director at Burrill & Company, a San Francisco based life science venture capital firm. While with Burrill, Sanuj served as an Observer on the Boards of diaDexus and Proventys, and played an active role in several other investments including Endocyte, Neosil, Cardiokine and Arete. In addition, Sanuj led Burrill’s India group, through which he assisted a number of portfolio companies in establishing collaborations with Indian companies. Previously, Sanuj worked in the Healthcare Investment Banking Group at Merrill Lynch where he assessed financing and M&A candidates for a variety of biotechnology and pharmaceutical clients.

Sanuj is Board Certified in Internal Medicine and completed his residency training at Thomas Jefferson University Hospital. Complementing his clinical experience, Sanuj was a National Cancer Institute Research Fellow at Memorial Sloan Kettering Cancer Center, and has published work in a variety of clinical disciplines. Sanuj received a BA with Honors from Northwestern University, an MD from Jefferson Medical College, and an MBA from The Kellogg School of Management, where he was a Rothschild Scholar.


MODERATOR

Amit Patel is Vice President of Corporate Development & Strategic Planning at Dr. Reddy's Laboratories, a publicly-traded (NYSE: RDY), India-based, global pharmaceutical company with $1 billion+ in annual revenue, 8000 employees, and operations in over 40 countries. Amit's primary responsibilities include chairing the Dr. Reddy's Global Business Development Council, building partnerships and alliances, pursuing mergers and acquisitions, and driving strategic growth initiatives. He is also involved in long-term strategic business planning and certain specific operational oversight within Dr. Reddy's North American operations.

Amit was previously co-founder and CEO of a healthcare software startup called MedOnTime that was later acquired by CTIS, at which he served as Vice President of Corporate Development. Earlier, Amit was a strategy consultant with Marakon Associates focusing on mergers and acquisitions. Amit received a B.S. in Economics from the Wharton School at the University of Pennsylvania, a B.A.S. in Systems Engineering from the Moore School at the University of Pennsylvania, and an MBA from Harvard Business School.